Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | CHUN-JEN LIU ; Chang J.; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Yang M.-D.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | World Journal of Gastroenterology | 53 | 51 | |
1999 | Annual risk of tuberculous infection in Taiwan, 1996-1998 | Yu M.-C.; Suo J.; Huang C.; Bai K.-J.; Lin T.-P.; KWEN-TAY LUH | Journal of the Formosan Medical Association | 26 | 19 | |
2017 | Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia | Ng A.W.T.; Poon S.L.; Huang M.N.; Lim J.Q.; Boot A.; Yu W.; Suzuki Y.; Thangaraju S.; Ng C.C.Y.; Tan P.; Pang S.-T.; Huang H.-Y.; Yu M.-C.; PO-HUANG LEE ; Hsieh S.-Y.; Chang A.Y.; Teh B.T.; Rozen S.G. | Science Translational Medicine | 265 | 237 | |
2011 | Clinical and microbiological characteristics of urine culture-confirmed genitourinary tuberculosis at medical centers in Taiwan from 1995 to 2007 | Hsu H.-L.; Lai C.-C.; Yu M.-C.; Yu F.-L.; Lee J.-C.; Chou C.-H.; Tan C.-K.; PAN-CHYR YANG ; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 11 | 10 | |
1998 | Drug resistance patterns of tuberculosis in Taiwan | Chiang I.-H.; Yu M.-C.; Bai K.-J.; Wu M.-P.; Hsu C.-J.; Lin T.-P.; KWEN-TAY LUH | Journal of the Formosan Medical Association | 23 | 18 | |
2020 | Effect of ventilation improvement during a tuberculosis outbreak in underventilated university buildings | Du C.-R.; Wang S.-C.; Yu M.-C.; Chiu T.-F.; JANN-YUAN WANG ; Chuang P.-C.; Jou R.; Chan P.-C.; CHI-TAI FANG | Indoor Air | 47 | 32 | |
2015 | Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study | JANN-YUAN WANG ; Lee C.-H.; Yu M.-C.; Lee M.-C.; LI-NA LEE ; JANN-TAY WANG | European Respiratory Journal | 11 | 9 | |
2009 | Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage | CHUN-JEN LIU ; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Lee C.-C.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | Journal of Hepatology | 131 | 125 | |
1997 | In vitro activity of ofloxacin against Mycobacterium tuberculosis | Yu M.-C.; Suo J.; Lin T.-P.; KWEN-TAY LUH | Journal of the Formosan Medical Association | 15 | 12 | |
2000 | In vitro activity of rifabutin and rifampin against clinical isolates of Mycobacterium tuberculosis in Taiwan | Chien H.-P.; Yu M.-C.; Ong T.-F.; Lin T.-P.; KWEN-TAY LUH | Journal of the Formosan Medical Association | 14 | 10 | |
2015 | The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis | Chiang C.Y.; Bai K.J.; HSIEN-HO LIN ; Chien S.T.; Lee J.J.; Enarson D.A.; Lee T.-I.; Yu M.-C. | PLoS ONE | 81 | 79 | |
2015 | Inhaled corticosteroids increase the risk of pneumonia in patients with chronic obstructive pulmonary disease: A nationwide cohort study | Lee M.-C.; Lee C.-H.; Chien S.-C.; Chang J.-H.; She H.-L.; JANN-YUAN WANG ; Yu M.-C. | Medicine (United States) | 19 | 22 | |
1997 | Initial drug resistance of Mycobacterium tuberculosis in Taiwan | Yu M.-C.; Suo J.; Chiang C.-Y.; Bai K.-J.; Lin T.-P.; KWEN-TAY LUH | Journal of the Formosan Medical Association | 19 | 17 | |
2015 | Light-emitting diode irradiation promotes donor site wound healing of the free gingival graft | CHEN-YING WANG ; Tsai S.-C.; Yu M.-C.; Lin Y.-F.; Chen C.-C.; PO-CHUN CHANG | Journal of Periodontology | 25 | 22 | |
2011 | Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: Prevalence, risk factors, and dominant strain | JANN-YUAN WANG ; Hsu H.-L.; Yu M.-C.; Chiang C.-Y.; Yu F.-L.; CHONG-JEN YU ; LI-NA LEE ; PAN-CHYR YANG | Clinical Microbiology and Infection | 24 | 21 | |
2018 | Modulation of periodontitis progression using pH-responsive nanosphere encapsulating metronidazole or N-phenacylthialzolium bromide | Lin J.-H.; Feng F.; Yu M.-C.; Wang C.-H.; PO-CHUN CHANG | Journal of Periodontal Research | 31 | 25 | |
2015 | Mycobacterium tuberculosis nucleic acid amplification tests reduce nosocomial tuberculosis exposure in intensive care units: A nationwide cohort study | JANN-YUAN WANG ; Lee M.-C.; Chang J.-H.; Yu M.-C.; VIN-CENT WU ; Huang K.-L.; Chao K.-M.; Chao K.-M.; Lee C.-H. | Respirology | 9 | 7 | |
2015 | Nine-to twelve-month anti-tuberculosis treatment is associated with a lower recurrence rate than 6-9-month treatment in human immunodeficiency virus-infected patients: A retrospective population-based cohort study in Taiwan | JANN-YUAN WANG ; HSIN-YUN SUN ; JANN-TAY WANG ; CHIEN-CHING HUNG ; Yu M.-C.; Lee C.-H.; LI-NA LEE | PLoS ONE | 11 | 11 | |
2008 | Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: The incidence, patient characteristics, and clinical significance | CHIN-CHUNG SHU ; Lee C.-H.; JANN-YUAN WANG ; JIH-SHUIN JERNG ; CHONG-JEN YU ; PO-REN HSUEH ; LI-NA LEE ; PAN-CHYR YANG ; Su W.-J.; HSIN-CHIH LAI ; Lee C.-H.; Yu M.-C. | Intensive Care Medicine | 34 | 31 | |
2015 | Outcome correlation of smear-positivity but culture-negativity during standard anti-tuberculosis treatment in Taiwan | Chao W.-C.; Huang Y.-W.; Yu M.-C.; Yang W.-T.; Lin C.-J.; Lee J.-J.; Huang R.-M.; Shieh C.-C.; Chien S.-T.; JUNG-YIEN CHIEN | BMC Infectious Diseases | 5 | 4 |